BBIO
Congressional ActivityBridgeBio Pharma, Inc. - Common
Stock (BBIO) [ST]
ARIA INTELLIGENCE BRIEF
Disclosure filings for this Health Care sector security show a single member of Congress, Gil Cisneros, accounting for all seven disclosed trades — each of which is a purchase, with no sales recorded in the public record. Activity in the name spans from August 2025 through May 2026, placing the most recent disclosed transaction within the past year. No bipartisan co-trading clusters are present, as only one member has disclosed activity, and no executive-branch officials have filed transactions in this security within the public disclosure record.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
7
BUYS
7
SELLS
0
MEMBERS
1
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+6.67%
vs SPY benchmark
BBIO timeline6 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
⚡
ACTIVE CONVERGENCE SIGNAL
A cabinet official and a congressional member both purchased this ticker within 30 days. See /executive for full detail.
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Trump, Donald J. President | May 18, 26 | BUY | $1K–$15K |
7 trades
Congressional trading data from STOCK Act filings. Not investment advice.